Clinical Nuclear Medicine · 2014 · 13 citations · 9 references
MedicineNuclear MedicineRadiologyBone ScintigraphyDiagnostic RadiologyNeoplasiaBone Metabolism DisordersBone PathologyBone Tumor ImagingBone TumorsMetabolic Bone Disease ImagingMetastatic Bone DiseaseHistopathologic ConfirmationHistopathologic ExaminationIntramedullary TumorsOsteomalacia ImagingSomatostatin Receptor ScintigraphyTumor-induced OsteomalaciaWhole-body Bone ScintigraphyWhole-body Scintigraphy
A 32-year-old woman presented with progressive myalgia, bone pain, fatigue, insufficiency hip fractures, high urine phosphate, and low serum phosphate and vitamin D levels. These findings were suggestive of oncogenic osteomalacia. A whole-body Tc-octreotide scintigraphy with SPECT/CT showed uptake on a sclerotic intramedullary lesion in the left medial tibia plateau. MRI depicted a solid lesion. The lesion was surgically removed; the patient became asymptomatic, and follow-up laboratory results normalized. Histopathologic examination revealed a vascular hemangiopericytoma-like tumor, positive for somatostatin receptor (SSR-2). Whole-body Tc-octreotide scintigraphy with SPECT/CT may detect occult oncogenic osteomalacia tumors.
9
Oncogenic osteomalacia — Hypophosphataemic spectrum from “benignancy” to “malignancy”
Paul T.L. Chiam, Hong Chang Tan, Yong Mong Bee et al. · Bone · 2012 · 30 citations
Medicine, Oncology, Pathobiology +16
A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan.
Silvia Casari, Verónica Rossi, M. Varenna et al. · PubMed · 2004 · 27 citations
Medicine, Nuclear Medicine, Oncology +17